Search research articles
Contact Us
Filters
Showing results (21-30 of 108) with videos related to
Page
of 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 2, 2019
How to Train Your T Cells: Overcoming Immune Dysfunction in Multiple Myeloma
Adam D Cohen, Noopur Raje, Jessica A Fowler, et al.
Hematology/Oncology Clinics of North America
|
December 29, 2023
Chimeric Antigen Receptor T Cells in the Treatment of Multiple Myeloma
Zainul S Hasanali, Beatrice Razzo, Sandra P Susanibar-Adaniya, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 9, 2021
Carfilzomib-Induced Atypical Hemolytic Uremic Syndrome in a Patient With Heterozygous CFHR3/CFHR1 Deletion Treated With Eculizumab
Craig W Freyer, Erin M Bange, Sarah Skuli, et al.
Clinical Case Reports
|
November 13, 2023
Multiple airway plasmacytomas: A rare cause of proximal airway obstruction requiring tumor debulking
Christopher Ghiathi, Ashley N Barlev, Gabriel C Caponetti, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 16, 2024
Practical Aspects of Immunotherapy: A Report from the 20th International Myeloma Society (IMS) Annual Meeting
Noopur S Raje, Adam D Cohen, Krina K Patel, et al.
Blood Advances
|
August 28, 2019
Serial treatment of relapsed/refractory multiple myeloma with different BCMA-targeting therapies
Adam D Cohen, Alfred L Garfall, Ahmet Dogan, et al.
The Lancet. Haematology
|
December 22, 2015
Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study
Scott F Huntington, Brendan M Weiss, Dan T Vogl, et al.
The Journal of Experimental Medicine
|
May 6, 2009
OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis
Daniel Hirschhorn-Cymerman, Gabrielle A Rizzuto, Taha Merghoub, et al.
Blood Cancer Journal
|
April 28, 2026
Immune effector cell-associated enterocolitis post-BCMA directed CAR T-cell therapy: insights from a multicenter case series
Sandra Susanibar-Adaniya, Benjamin A Derman, Adam D Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 23, 2015
A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma
Don M Benson, Adam D Cohen, Sundar Jagannath, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 108) with videos related to
Sort By:
Page
of 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 2, 2019
How to Train Your T Cells: Overcoming Immune Dysfunction in Multiple Myeloma
Adam D Cohen, Noopur Raje, Jessica A Fowler, et al.
Hematology/Oncology Clinics of North America
|
December 29, 2023
Chimeric Antigen Receptor T Cells in the Treatment of Multiple Myeloma
Zainul S Hasanali, Beatrice Razzo, Sandra P Susanibar-Adaniya, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 9, 2021
Carfilzomib-Induced Atypical Hemolytic Uremic Syndrome in a Patient With Heterozygous CFHR3/CFHR1 Deletion Treated With Eculizumab
Craig W Freyer, Erin M Bange, Sarah Skuli, et al.
Clinical Case Reports
|
November 13, 2023
Multiple airway plasmacytomas: A rare cause of proximal airway obstruction requiring tumor debulking
Christopher Ghiathi, Ashley N Barlev, Gabriel C Caponetti, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
April 16, 2024
Practical Aspects of Immunotherapy: A Report from the 20th International Myeloma Society (IMS) Annual Meeting
Noopur S Raje, Adam D Cohen, Krina K Patel, et al.
Blood Advances
|
August 28, 2019
Serial treatment of relapsed/refractory multiple myeloma with different BCMA-targeting therapies
Adam D Cohen, Alfred L Garfall, Ahmet Dogan, et al.
The Lancet. Haematology
|
December 22, 2015
Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study
Scott F Huntington, Brendan M Weiss, Dan T Vogl, et al.
The Journal of Experimental Medicine
|
May 6, 2009
OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis
Daniel Hirschhorn-Cymerman, Gabrielle A Rizzuto, Taha Merghoub, et al.
Blood Cancer Journal
|
April 28, 2026
Immune effector cell-associated enterocolitis post-BCMA directed CAR T-cell therapy: insights from a multicenter case series
Sandra Susanibar-Adaniya, Benjamin A Derman, Adam D Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 23, 2015
A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma
Don M Benson, Adam D Cohen, Sundar Jagannath, et al.
Page
of 11